217 related articles for article (PubMed ID: 20002560)
41. Factors associated with liver fibrosis in intravenous drug users coinfected with HIV and HCV.
Cartón JA; Collazos J; de la Fuente B; García-Alcalde ML; Suarez-Zarracina T; Rodríguez-Guardado A; Asensi V
Antivir Ther; 2011; 16(1):27-35. PubMed ID: 21311106
[TBL] [Abstract][Full Text] [Related]
42. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
43. Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance.
Blanco F; Barreiro P; Ryan P; Vispo E; Martín-Carbonero L; Tuma P; Labarga P; Medrano J; González-Lahoz J; Soriano V
J Viral Hepat; 2011 Jan; 18(1):11-6. PubMed ID: 20088890
[TBL] [Abstract][Full Text] [Related]
44. Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.
Larsen C; Bousquet V; Delarocque-Astagneau E; Pioche C; Roudot-Thoraval F; ; ; Desenclos JC
J Med Virol; 2010 Oct; 82(10):1647-54. PubMed ID: 20827760
[TBL] [Abstract][Full Text] [Related]
45. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
Murcia J; Portilla J; Bedia M; Palazón JM; Sánchez-Payá J; Saiz de la Hoya P; Payá A; Boix V; Merino E; Reus S
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
[TBL] [Abstract][Full Text] [Related]
46. Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients.
Merchante N; Rivero A; de Los Santos-Gil I; Merino D; Márquez M; López-Ruz MA; Rodríguez-Baño J; Del Valle J; Camacho A; Sanz-Sanz J; Macías J; Pérez-Camacho I; Gómez-Mateos J; Moro A; Pineda JA
Gut; 2009 Dec; 58(12):1654-60. PubMed ID: 19625279
[TBL] [Abstract][Full Text] [Related]
47. The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
Núñez-Torres R; Macías J; Mancebo M; Frías M; Dolci G; Téllez F; Merino D; Merchante N; Gómez-Mateos J; Guaraldi G; Rivero-Juárez A; Pineda JA; Real LM;
PLoS One; 2016; 11(12):e0168265. PubMed ID: 27973562
[TBL] [Abstract][Full Text] [Related]
48. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus.
Sánchez-Conde M; Montes Ramírez ML; Bellón Cano JM; Caminoa A; Alvarez Rodríguez F; González Garcia J; Miralles Martín P; Bernardino de la Serna I; Bernardo de Quirós JC; Arribas López JR; Cosín Ochaíta J; Pascual Pareja JF; Alvarez E; Berenguer JB
J Viral Hepat; 2011 Jul; 18(7):e278-83. PubMed ID: 21129129
[TBL] [Abstract][Full Text] [Related]
49. Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy.
Calvaruso V; Cammà C; Di Marco V; Maimone S; Bronte F; Enea M; Dardanoni V; Manousou P; Pleguezuelo M; Xirouchakis E; Attanasio M; Dusheiko G; Burroughs AK; Craxì A
J Viral Hepat; 2010 Jul; 17(7):469-74. PubMed ID: 19780940
[TBL] [Abstract][Full Text] [Related]
50. An artificial neural network improves the non-invasive diagnosis of significant fibrosis in HIV/HCV coinfected patients.
Resino S; Seoane JA; Bellón JM; Dorado J; Martin-Sanchez F; Alvarez E; Cosín J; López JC; Lopéz G; Miralles P; Berenguer J
J Infect; 2011 Jan; 62(1):77-86. PubMed ID: 21073895
[TBL] [Abstract][Full Text] [Related]
51. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
[TBL] [Abstract][Full Text] [Related]
52. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
[TBL] [Abstract][Full Text] [Related]
53. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
[TBL] [Abstract][Full Text] [Related]
54. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
55. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
Castéra L; Loko MA; Le Bail B; Coffie P; De Ledinghen V; Trimoulet P; Winnock M; Dabis F; Neau D;
Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1489-98. PubMed ID: 17903235
[TBL] [Abstract][Full Text] [Related]
56. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
Macías J; Mancebo M; Márquez M; Merino D; Téllez F; Rivero A; von Wichmann MA; López-Cortés LF; Merchante N; Santos J; Raffo M; Pérez-Pérez M; Camacho Á; Iribarren JA; Pineda JA
Hepatology; 2015 May; 61(5):1503-11. PubMed ID: 25545020
[TBL] [Abstract][Full Text] [Related]
57. Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy.
Fernández-Montero JV; Barreiro P; Vispo E; Labarga P; Sánchez-Parra C; Soriano V
AIDS; 2013 Apr; 27(7):1129-34. PubMed ID: 23276803
[TBL] [Abstract][Full Text] [Related]
58. Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infection.
Bruno R; Sacchi P; Cima S; Maiocchi L; Patruno SF; Klersy C; Barbarini G; Zuccaro V; Camma C; Filice G
Dig Liver Dis; 2011 Jul; 43(7):575-8. PubMed ID: 21596630
[TBL] [Abstract][Full Text] [Related]
59. Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysis.
Ingiliz P; Valantin MA; Preziosi P; Finzi L; Pais R; Fedchuk L; Dominguez S; Katlama C; Poynard T; Benhamou Y
J Hepatol; 2012 Jan; 56(1):49-54. PubMed ID: 21781946
[TBL] [Abstract][Full Text] [Related]
60. Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients.
Sánchez-Conde M; Miralles P; Bellón JM; Rincón D; Ramírez M; Gutiérrez I; Ripoll C; López JC; Cosín J; Clemente G; Lo Iacono O; Bañares R; Berenguer J
J Viral Hepat; 2011 Oct; 18(10):685-91. PubMed ID: 21914085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
